Literature DB >> 10196327

Adeno-associated virus (AAV) type 5 Rep protein cleaves a unique terminal resolution site compared with other AAV serotypes.

J A Chiorini1, S Afione, R M Kotin.   

Abstract

Adeno-associated virus (AAV) replication depends on two viral components for replication: the AAV nonstructural proteins (Rep) in trans, and inverted terminal repeat (ITR) sequences in cis. AAV type 5 (AAV5) is a distinct virus compared to the other cloned AAV serotypes. Whereas the Rep proteins and ITRs of other serotypes are interchangeable and can be used to produce recombinant viral particles of a different serotype, AAV5 Rep proteins cannot cross-complement in the packaging of a genome with an AAV2 ITR. In vitro replication assays indicated that the block occurs at the level of replication instead of at viral assembly. AAV2 and AAV5 Rep binding activities demonstrate similar affinities for either an AAV2 or AAV5 ITR; however, comparison of terminal resolution site (TRS) endonuclease activities showed a difference in specificity for the two DNA sequences. AAV2 Rep78 cleaved only a type 2 ITR DNA sequence, and AAV5 Rep78 cleaved only a type 5 probe efficiently. Mapping of the AAV5 ITR TRS identified a distinct cleavage site (AGTG TGGC) which is absent from the ITRs of other AAV serotypes. Comparison of the TRSs in the AAV2 ITR, the AAV5 ITR, and the AAV chromosome 19 integration locus identified some conserved nucleotides downstream of the cleavage site but little homology upstream.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196327      PMCID: PMC104210     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Inhibition of H-ras expression by the adeno-associated virus Rep78 transformation suppressor gene product.

Authors:  P L Hermonat
Journal:  Cancer Res       Date:  1991-07-01       Impact factor: 12.701

2.  Adeno-associated virus gene expression inhibits cellular transformation by heterologous genes.

Authors:  M A Labow; L H Graf; K I Berns
Journal:  Mol Cell Biol       Date:  1987-04       Impact factor: 4.272

3.  Evidence for covalent attachment of the adeno-associated virus (AAV) rep protein to the ends of the AAV genome.

Authors:  R O Snyder; D S Im; N Muzyczka
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

4.  The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity.

Authors:  D S Im; N Muzyczka
Journal:  Cell       Date:  1990-05-04       Impact factor: 41.582

5.  The adeno-associated virus Rep78 gene inhibits cellular transformation induced by bovine papillomavirus.

Authors:  P L Hermonat
Journal:  Virology       Date:  1989-09       Impact factor: 3.616

6.  Mutagenesis of an AUG codon in the adeno-associated virus rep gene: effects on viral DNA replication.

Authors:  N Chejanovsky; B J Carter
Journal:  Virology       Date:  1989-11       Impact factor: 3.616

7.  Inhibition of cellular transformation by the adeno-associated virus rep gene.

Authors:  S N Khleif; T Myers; B J Carter; J P Trempe
Journal:  Virology       Date:  1991-04       Impact factor: 3.616

8.  Adeno-associated virus rep proteins produced in insect and mammalian expression systems: wild-type and dominant-negative mutant proteins bind to the viral replication origin.

Authors:  R A Owens; J P Trempe; N Chejanovsky; B J Carter
Journal:  Virology       Date:  1991-09       Impact factor: 3.616

9.  In vitro rescue of an integrated hybrid adeno-associated virus/simian virus 40 genome.

Authors:  P Ward; K I Berns
Journal:  J Mol Biol       Date:  1991-04-20       Impact factor: 5.469

10.  The adeno-associated virus rep gene inhibits replication of an adeno-associated virus/simian virus 40 hybrid genome in cos-7 cells.

Authors:  M A Labow; K I Berns
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

View more
  31 in total

1.  DNA sequence motifs which direct adeno-associated virus site-specific integration in a model system.

Authors:  P Meneses; K I Berns; E Winocour
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Characterization of the transcription profile of adeno-associated virus type 5 reveals a number of unique features compared to previously characterized adeno-associated viruses.

Authors:  Jianming Qiu; Ramnath Nayak; Gregory E Tullis; David J Pintel
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Structural Studies of AAV2 Rep68 Reveal a Partially Structured Linker and Compact Domain Conformation.

Authors:  Faik N Musayev; Francisco Zarate-Perez; Martino Bardelli; Clayton Bishop; Emil F Saniev; R Michael Linden; Els Henckaerts; Carlos R Escalante
Journal:  Biochemistry       Date:  2015-09-14       Impact factor: 3.162

4.  Highly divergent integration profile of adeno-associated virus serotype 5 revealed by high-throughput sequencing.

Authors:  Tyler Janovitz; Thiago Oliveira; Michel Sadelain; Erik Falck-Pedersen
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

5.  Therapeutic strategies for the inherited neuropathies.

Authors:  Michael E Shy
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

6.  Efficient expression of the adeno-associated virus type 5 p41 capsid gene promoter in 293 cells does not require Rep.

Authors:  Chaoyang Ye; Jianming Qiu; David J Pintel
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

7.  Upstream AP1- and CREB-binding sites confer high basal activity on the adeno-associated virus type 5 capsid gene promoter.

Authors:  Chaoyang Ye; David J Pintel
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

8.  AAV5-mediated gene transfer to the parotid glands of non-human primates.

Authors:  A Voutetakis; C Zheng; A P Cotrim; F Mineshiba; S Afione; N Roescher; W D Swaim; M Metzger; M A Eckhaus; R E Donahue; C E Dunbar; J A Chiorini; B J Baum
Journal:  Gene Ther       Date:  2009-09-17       Impact factor: 5.250

9.  Comparative transduction efficiency of AAV vector serotypes 1-6 in the substantia nigra and striatum of the primate brain.

Authors:  Eleni A Markakis; Kenneth P Vives; Jeremy Bober; Stefan Leichtle; Csaba Leranth; Jeff Beecham; John D Elsworth; Robert H Roth; R Jude Samulski; D Eugene Redmond
Journal:  Mol Ther       Date:  2009-12-15       Impact factor: 11.454

10.  Reducing the risk of adeno-associated virus (AAV) vector mobilization with AAV type 5 vectors.

Authors:  F Curtis Hewitt; Chengwen Li; Steven J Gray; Shelley Cockrell; Michael Washburn; R Jude Samulski
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.